bioRxivPathologyPreprint
Proteolytic program-dependent functions are impaired in INF2-mediated focal segmental glomerulosclerosis.
B. K. Subramanian, J. Chun, C. Perez, P. Yan, I. Stillman, H. Higgs, S. Alper, J. Schlondorff, M. Pollak
Abstract
Regulation of the actin cytoskeleton is critical for normal glomerular podocyte structure and function. Altered regulation of the podocyte cytoskeleton can lead to proteinuria, reduced kidney filtration function and focal segmental glomerulosclerosis (FSGS). Mutations in inverted formin 2 (INF2), a member of the formin family of actin regulatory proteins, are the most common cause of autosomal dominant FSGS. INF2 is a multi-domain protein regulated by interaction between its N-terminal Diaphanous Inhibitory Domain (DID) and its C-terminal Diaphanous Auto-regulatory Domain (DAD). Although many aspects of the INF2 DID-DAD interaction are understood, it remains unclear why disease-causing mutations are restricted to the DID and how these mutations cause human disease. Here we report a proteolytic cleavage in INF2 that liberates the INF2 N-terminal DID to function independently of the INF2 C-terminal fragment containing the DAD domain. N-terminal DID region epitopes are differentially localized to podocyte foot process structures in normal glomeruli. This N-terminal fragment localization is lost in INF2-mediated FSGS, whereas INF2 C-terminal fragment epitopes localize to the podocyte cell body in both normal and disease conditions. INF2 cleavage is mediated by cathepsin proteases. In cultured podocytes, the wild-type INF2 N-terminal fragment localizes to membrane regions and promotes cell spreading, while these functions are impaired in a disease-associated INF2 mutant R218Q in the DID. These features are dependent on INF2-cleavage, with accompanying interaction of INF2 N-fragment with mDIA1. Our data suggest a unique cellular function of the DID dependent on INF2 cleavage and help explain the altered localization of FSGS-associated INF2 mutant polypeptides.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Missense Mutant Gain-of-Function Causes Inverted Formin 2 (INF2)-Related Focal Segmental Glomerulosclerosis (FSGS)
Balajikarthick Subramanian, Sarah Williams, … Martin R. Pollak·bioRxiv·Jun 8, 2024
- A deregulated stress response underlies distinct INF2 associated disease profiles
S. Bayraktar, J. Nehrig, … R. Wedlich-Soldner·bioRxiv·Nov 12, 2019
- Protective role of podocytic IL-15/STAT5 pathway in experimental focal and segmental glomerulosclerosis
- A complex containing lysine-acetylated actin inhibits the formin INF2
M. A, T. S. Fung, … H. Higgs·bioRxiv·Dec 31, 2018
- Vincristine treatment reverses podocyte damage in focal segmental glomerulosclerosis
William J. Mason, Jennifer C. Chandler, … Ruth J. Pepper·Kidney International ReportsPeer-reviewed·Aug 15, 2025
- A Bigenic mouse model of FSGS reveals perturbed pathways in podocytes, mesangial cells and endothelial cells
A. S. Potter, K. Drake, … S. S. Potter·bioRxiv·Apr 18, 2019